M. [Georges] Mandel [16-1-20, pr��s du S��nat, vote pr��liminaire pour l'��lection du pr��sident de la R��publique] : [photographie de presse] / [Agence Rol]

R��f��rence bibliographique : Rol, 57663

17-1-20, Congr��s de Versailles, g��n��ral de Castelnau : [photographie de presse] / [Agence Rol]

R��f��rence bibliographique : Rol, 57682

8-12-19, g��n��ral de Castelnau arrivant �� la premi��re s��ance de la nouvelle chambre : [photographie de presse] / [Agence Rol]

R��f��rence bibliographique : Rol, 57179

ABD e-News - November 19, 2004

Weekly Newsletter

The Lausanne cohort Lc65+: a population-based prospective study of the manifestations, determinants and outcomes of frailty

BACKGROUND: Frailty is a relatively new geriatric concept referring to an increased vulnerability to stressors. Various definitions have been proposed, as well as a range of multidimensional instruments for its measurement. More recently, a frailty phenotype that predicts a range of adverse outcomes has been described. Understanding frailty is a particular challenge both from a clinical and a public health perspective because it may be a reversible precursor of functional dependence. The Lausanne cohort Lc65+ is a longitudinal study specifically designed to investigate the manifestations of frailty from its first signs in the youngest old, identify medical and psychosocial determinants, and describe its evolution and related outcomes. METHODS/DESIGN: The Lc65+ cohort was launched in 2004 with the random selection of 3054 eligible individuals aged 65 to 70 (birth year 1934-1938) in the non-institutionalized population of Lausanne (Switzerland). The baseline data collection was completed among 1422 participants in 2004-2005 through questionnaires, examination and performance tests. It comprised a wide range of medical and psychosocial dimensions, including a life course history of adverse events. Outcomes measures comprise subjective health, limitations in activities of daily living, mobility impairments, development of medical conditions or chronic health problems, falls, institutionalization, health services utilization, and death. Two additional random samples of 65-70 years old subjects will be surveyed in 2009 (birth year 1939-1943) and in 2014 (birth year 1944-1948). DISCUSSION: The Lc65+ study focuses on the sequence "Determinants --> Components --> Consequences" of frailty. It currently provides information on health in the youngest old and will allow comparisons to be made between the profiles of aging individuals born before, during and at the end of the Second World War.

Impact of recommendation updates in well-controlled patients on nonrecommended antiretroviral therapies: the Swiss HIV cohort study.

BACKGROUND: HIV treatment recommendations are updated as clinical trials are published. Whether recommendations drive clinicians to change antiretroviral therapy in well-controlled patients is unexplored. METHODS: We selected patients with undetectable viral loads (VLs) on nonrecommended regimens containing double-boosted protease inhibitors (DBPIs), triple-nucleoside reverse transcriptase inhibitors (NRTIs), or didanosine (ddI) plus stavudine (d4T) at publication of the 2006 International AIDS Society recommendations. We compared demographic and clinical characteristics with those of control patients with undetectable VL not on these regimens and examined clinical outcome and reasons for treatment modification. RESULTS: At inclusion, 104 patients were in the DBPI group, 436 in the triple-NRTI group, and 19 in the ddI/d4T group. By 2010, 28 (29%), 204 (52%), and 1 (5%) patient were still on DBPIs, triple-NRTIs, and ddI plus d4T, respectively. 'Physician decision,' excluding toxicity/virological failure, drove 30% of treatment changes. Predictors of recommendation nonobservance included female sex [adjusted odds ratio (aOR) 2.69, 95% confidence interval (CI) 1 to 7.26; P = 0.01] for DPBIs, and undetectable VL (aOR 3.53, 95% CI 1.6 to 7.8; P = 0.002) and lack of cardiovascular events (aOR 2.93, 95% CI 1.23 to 6.97; P = 0.02) for triple-NRTIs. All patients on DBPIs with documented diabetes or a cardiovascular event changed treatment. Recommendation observance resulted in lower cholesterol values in the DBPI group (P = 0.06), and more patients having undetectable VL (P = 0.02) in the triple-NRTI group. CONCLUSION: The physician's decision is the main factor driving change from nonrecommended to recommended regimens, whereas virological suppression is associated with not switching. Positive clinical outcomes observed postswitch underline the importance of observing recommendations, even in well-controlled patients.

El ni��o eterno: un acercamiento m��tico al personaje Charlot

Este trabajo pretende realizar un acercamiento m��tico al personaje c��mico Charlot a trav��s de un an��lisis de los cinco largometrajes realizados por Charles Chaplin teniendo como protagonista el vagabundo: El chico (The kid, 1921), La quimera del oro (The gold rush, 1925), El circo (The circus, 1928), Luces de la ciudad (City lights, 1931) y Tiempos modernos (Modern times,1936). Buscaremos ampliar la comprensi��n de este personaje a trav��s de la figura arquet��pica del ���ni��o eterno��� ��� el puer aeternus ���, y desde dos perspectivas distintas: el tiempo y el espacio. El primer cap��tulo trata deentender c��mo las manifestaciones m��gicas y sincr��nicas del tiempocomponen la narrativa y el montaje de las pel��culas; el segundo busca verificarde qu�� manera la paradoja nost��lgica que impulsa y detiene el movimiento deCharlot organiza el espacio f��lmico

Comparaci�� de les dues traduccions al catal�� de This Side of Paradise

En aquest treball es fa una an��lisi de This Side of Paradise, de Scott Fitzgerald, enfocada a avaluar les traduccions catalanes. A continuaci��, es comparen les dues traduccions existents: una de Francesc Parcerisas (Aquest costat del parad��s, 1984) i l���altra de Josep Maria Fulquet (En aquest costat del parad��s, 2003).

Virkamiesten virkalomat

Puhe